The Cancer

Don't Miss

FDA Clears Protocol Replace for Tasquinimod in Myelofibrosis Trial

Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...

How Most cancers Stole My Peace of Thoughts and Taught Me Resilience

Being robbed is simply part of life.Once I was in grammar college, little girls and boys would copy off my exams, stealing my solutions to...

FDA Clears PD-L1 Check to Information Keytruda Use in Ovarian Most cancers

The U.S. Meals and Drug Administration (FDA) has accepted PD-L1 IHC 22C3 pharmDx, Code SK006, as a companion diagnostic to assist establish sufferers with epithelial...

Vital Information

Facts

Latest Articles

Using Biomarkers in Most cancers Prevention, Analysis, and Therapy

On this interview, Grace Liu from Sino Organic discusses the essential...

Most cancers Cachexia: Uncovered – BioTechniques

Teresa Zimmers (left) runs a laboratory on the Oregon Well being and Science College (OR, USA) targeted on the research of cachexia, the...

CAR-T cell remedy in stable tumors

Chimeric antigen receptor-T cell (CAR-T) remedy has proven a fantastic profit in sufferers with hematologic and lymphatic cancers. Nonetheless,...

Novel meriolin derivatives potently inhibit cell cycle development and transcription in leukemia and lymphoma cells by way of inhibition of cyclin-dependent kinases (CDKs)

Malumbres M, Harlow E, Hunt T, Hunter T, Lahti JM, Manning G, et al. Cyclin-dependent kinases: a household portrait. Nat Cell Biol. 2009;11:1275–6.Article  ...

Courageous mind tumour woman jets off for life-saving vaccine after public increase £300k

Ava Bolton, from East Ayrshire, was identified with childhood most cancers neuroblastoma which she has efficiently fought, and is now flying to the...

Hot Topics